Catharanthine, an anticancer vinca alkaloid: an in silico and in vitro analysis of the autophagic system as the major mechanism of cell death in liver HepG2 cells
Authors:
- Farnoosh GholamiFGFarnoosh Gholami
- Bagher SeyedalipourBSBagher Seyedalipour
- Nafiseh Heidari-KalvaniNHNafiseh Heidari-Kalvani
- Mohsen Nabi-AfjadiMNMohsen Nabi-Afjadi
- Mohammad Yaghoubzad-MalekiMYMohammad Yaghoubzad-Maleki
- Zeinab FathiZFZeinab Fathi
- Iraj AlipourfardIAIraj Alipourfard
- Fereshte BarjestehFBFereshte Barjesteh
- Elham BahreiniEBElham Bahreini
- 10 June 2024
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 397 (11) , 8879-8892
Abstract
Catharanthine, a component of the anticancer drug vinblastine along with vindoline, disrupts the cell cycle by interfering with mitotic spindle formation. Apart from their antioxidant properties, vinca alkaloids like catharanthine inhibit phosphodiesterase activity and elevate intracellular cAMP levels. The aim of this study was to investigate how catharantine affects apoptosis and autophagy. This study conducted experiments on HepG2 liver carcinoma cells with varying doses of catharanthine to evaluate cell death rates and viability and determine the IC50 concentration via MTT assays. The apoptotic and autophagic effects of catharanthine were assessed using flow cytometry with annexin V and PI staining, while the expression of autophagy-related genes was analyzed through quantitative PCR. Additionally, molecular docking and molecular dynamics simulations were employed to further investigate catharanthine’s impact on autophagy mechanisms. The study showed that catharanthine reduced oxidative stress and triggered apoptosis in HepG2 cells in a dose-dependent manner. Catharanthine also upregulated the expression of autophagy-related genes like LC3, Beclin1, and ULK1. Notably, catharanthine increased sirtuin-1 levels, a known autophagy inducer, while decreasing Akt expression compared to untreated cells. Molecular docking results indicated rapamycin had a stronger binding affinity with FRB (−10.7 KJ/mol−1) than catharanthine (−7.3 KJ/mol−1). Additionally, molecular dynamics simulations revealed that catharanthine interacted effectively with the FRB domain of mTOR, displaying stability and a strong binding affinity, although not as potent as rapamycin. In summary, besides its cytotoxic and pro-apoptotic effects, catharanthine activates autophagy signaling pathways and induces autophagic necrosis by inhibiting mTOR.Keywords
All Related Versions
This publication has 55 references indexed in Scilit:
- The cellular decision between apoptosis and autophagyChinese Journal of Cancer, 2012
- cAMP induces autophagy via a novel pathway involving ERK, cyclin E and Beclin 1Autophagy, 2011
- AMPK and mTOR coordinate the regulation of Ulk1 and mammalian autophagy initiationAutophagy, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- A review of the herbal phosphodiesterase inhibitors; Future perspective of new drugsCytokine, 2010
- Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagyCell Death & Disease, 2010
- Regulation of AMP-activated protein kinase by cAMP in adipocytes: Roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysisCellular Signalling, 2009
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Inhibition of calmodulin-dependent Calcium-ATPase and phosphodiesterase by various cyclopeptides and peptide alkaloids from the zizyphus speciesArchives of Pharmacal Research, 2001